SCHEMBL30737186

SCHEMBL30737186

C#CCOCCOCCOCCOCCOCCOCCOCC(=O)N[C@@H](Cc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.47
TDP1 Q9NUW8 4/20 0.47
POLB P06746 3/20 0.47
KLK5 Q9Y337 1/20 0.47
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
KMT2A Q03164 1/20 0.47
ITGA4 P13612 2/20 0.45
ITGB7 P26010 2/20 0.45
ACE P12821 1/20 0.45
MAOA P21397 1/20 0.45
CTSS P25774 2/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CTSK P43235 1/20 0.44
MMP1 P03956 1/20 0.44
MMP3 P08254 1/20 0.44
MMP9 P14780 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30737274 0.86 GPR34 (0.47) TDP1LMNAACENPSR1
SCHEMBL30737295 0.83 ALDH1A1 (0.46) KLK5ALDH1A1MEN1LMNAKMT2A
SCHEMBL19578825 0.82 MEN1 (0.54) MAPTTDP1POLBKLK5ALDH1A1
SCHEMBL19567163 0.77 MAPT (0.58) MAPTTDP1POLBKLK5ALDH1A1
SCHEMBL10076050 0.77 MAPT (0.58) MAPTTDP1POLBKLK5ALDH1A1
SCHEMBL11049924 0.76 ALDH1A1 (0.58) POLBALDH1A1MEN1LMNAKMT2A
SCHEMBL15610733 0.76 MAPT (0.57) MAPTTDP1POLBKLK5ALDH1A1
SCHEMBL15624933 0.76 MAPT (0.57) MAPTTDP1POLBKLK5ALDH1A1
SCHEMBL15421626 0.76 ITGA4 (0.61) MAPTTDP1POLBKLK5ITGA4
SCHEMBL27140801 0.76 MAPT (0.57) MAPTTDP1POLBKLK5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2025-11-13 US disclosed
EP-4543858-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES Draupnir Bio ApS (DK) 2025-04-30 EP disclosed
WO-2023247754-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES SORT1, SCARB1, LAMP1 MAPT 3361/4885TDP1 2734/4885POLB 4345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.